ebomi
Colour theme
Sign in
Insider · CIK 0001640031

NEA Partners 15, L.P.

CIK 0001640031 Name as filed on the most recent filing

Filed as NEA Partners 15, L.P. (26)

40 transaction lines · from 26 filings · filed 2016-12-19 to 2025-10-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-10-02 S, Open-market sale NeueHealth, Inc.NEUE 1,890, disposed Open Form 4 filing 0001193125-25-232128
2022-06-21 P, Open-market purchase Arcellx, Inc.ACLX 5,000,000, acquired Open Form 4 filing 0001209191-22-038994
2022-05-31 S, Open-market sale IonQ, Inc.IONQ 2,815,374, disposed Open Form 4 filing 0001209191-22-032835
2022-05-27 S, Open-market sale IonQ, Inc.IONQ 8,880,359, disposed Open Form 4 filing 0001209191-22-032835
2022-05-26 S, Open-market sale IonQ, Inc.IONQ 5,377,726, disposed Open Form 4 filing 0001209191-22-032835
2022-02-08 P, Open-market purchase Arcellx, Inc.ACLX 23,749,995, acquired Open Form 4 filing 0001209191-22-008192
2021-04-13 P, Open-market purchase Reneo Pharmaceuticals, Inc.RPHM 9,999,990, acquired Open Form 4 filing 0001209191-21-026862
2020-10-20 P, Open-market purchase Eargo, Inc.EAR 5,599,998, acquired Open Form 4 filing 0001209191-20-055616
2020-07-28 P, Open-market purchase Inozyme Pharma, Inc.INZY 4,000,000, acquired Open Form 4 filing 0001209191-20-043880
2020-07-14 P, Open-market purchase Nkarta, Inc.NKTK 11,999,988, acquired Open Form 4 filing 0001209191-20-042657
2020-06-19 P, Open-market purchase Aveo Pharmaceuticals, Inc.AVEO 7,499,998, acquired Open Form 4 filing 0001209191-20-038234
2019-04-08 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 4,956,523, acquired Open Form 4 filing 0001209191-19-023995
2018-12-21 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 448,380, acquired Open Form 4 filing 0001209191-18-064024
2018-12-20 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 326,060, acquired Open Form 4 filing 0001209191-18-064024
2018-12-11 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 121,084, acquired Open Form 4 filing 0001209191-18-062247
2018-12-10 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 51,576, acquired Open Form 4 filing 0001209191-18-061832
2018-12-07 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 232,362, acquired Open Form 4 filing 0001209191-18-061832
2018-12-06 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 54,414, acquired Open Form 4 filing 0001209191-18-061832
2018-11-30 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 142,067, acquired Open Form 4 filing 0001209191-18-060414
2018-11-28 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 48,824, acquired Open Form 4 filing 0001209191-18-060414
2018-11-20 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 336,107, acquired Open Form 4 filing 0001209191-18-059729
2018-11-19 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 956,658, acquired Open Form 4 filing 0001209191-18-059344
2018-11-16 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 649,355, acquired Open Form 4 filing 0001209191-18-059344
2018-11-15 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 631,958, acquired Open Form 4 filing 0001209191-18-059344
2018-08-21 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 1,499,998, acquired Open Form 4 filing 0001209191-18-047958
2018-07-19 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 101,165, acquired Open Form 4 filing 0001209191-18-043476
2018-07-18 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 390,580, acquired Open Form 4 filing 0001209191-18-043476
2018-06-28 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 392,692, acquired Open Form 4 filing 0001209191-18-039956
2018-06-27 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 11,384, acquired Open Form 4 filing 0001209191-18-039956
2018-05-30 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 591, acquired Open Form 4 filing 0001209191-18-034183
2018-05-21 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 69,059, acquired Open Form 4 filing 0001209191-18-031981
2018-05-18 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 42,928, acquired Open Form 4 filing 0001209191-18-031981
2018-05-17 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 391,436, acquired Open Form 4 filing 0001209191-18-031981
2018-05-08 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 151,250, acquired Open Form 4 filing 0001209191-18-029293
2018-04-10 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 499,994, acquired Open Form 4 filing 0001209191-18-024532
2018-04-09 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 78,099, acquired Open Form 4 filing 0001209191-18-024532
2018-04-06 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 1,536,943, acquired Open Form 4 filing 0001209191-18-024532
2018-02-26 S, Open-market sale Arca biopharma, Inc.ABIO 731,273, disposed Open Form 4 filing 0001209191-18-013927
2017-03-28 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 3,000,000, acquired Open Form 4 filing 0001209191-17-023485
2016-12-19 P, Open-market purchase Achaogen IncAKAO 6,750,000, acquired Open Form 4 filing 0001209191-16-155933

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. NEA Partners 15, L.P., insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001640031

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.